Percheron Therapeutics Ltd (PER) — Cash Flow Reinvestment Rate

Latest as of September 2015: 0.01x

Percheron Therapeutics Ltd (PER) has a Cash Flow Reinvestment Rate of 0.01x as of September 2015, reinvesting AU$1.90K (capex AU$1.90K ) from operating cash flow of AU$317.22K. Check Percheron Therapeutics Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.90K

Capex + Investments

Operating Cash Flow

AU$317.22K

AUD

Capital Expenditures

AU$1.90K

AUD

Percheron Therapeutics Ltd Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Percheron Therapeutics Ltd across 1 annual periods. Explore Percheron Therapeutics Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Percheron Therapeutics Ltd (2015–2015)

Year-by-year capital reinvestment analysis for Percheron Therapeutics Ltd. For live market cap and broader valuation context, see Percheron Therapeutics Ltd (PER) total market value.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2015	1.89x	AU$2.40 Million	AU$1.27 Million	AU$3.86K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow